Pfizer

New Delhi: Pfizer has reportedly suspended the sale and use of some of its popular products in India. The move came after some technical issues. The matter is being investigated by the manufacturer. As per reports, the products whose…
Read More...

New York: Biotechnology major Moderna on Friday sued rival Pfizer and BioNTech over alleged infringement of its messenger RNA (mRNA) vaccine technology patents. In the lawsuit filed in the US and Germany, Moderna alleged that Pfizer and…
Read More...

Ottawa: Canada's drug regulator announced it has authorised Pfizer-BioNTech Comirnaty Covid-19 vaccine for use as a booster dose in children aged 5 to 11 years. Health Canada said this booster dose provides a great option to restore…
Read More...

Davos: Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries and is talking to other big drugmakers about similar steps, The Guardian…
Read More...

New York: An antiviral drug, developed by Pfizer to treat SARS-CoV-2, remains effective against the newest variants of the evolving Covid-19 virus, according to researchers. Researchers from the Rutgers University in the US showed that…
Read More...

Washington: The US Food and Drug Administration (FDA) has scheduled a virtual meeting of its advisors on February 15 to discuss the request for emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for use in children 6…
Read More...

Hong Kong: Despite low absolute risk, there is an increased relative risk of carditis a type of heart inflammation associated with Covid vaccine developed by US drugmaker Pfizer and China's CoronaVac, researchers have found. The…
Read More...

Washington: The US Food and Drug Administration (FDA) is likely to approve Pfizer's Covid vaccine for children under 5 years of age in February, White House chief medical advisor Anthony Fauci has said. According to Fauci, younger…
Read More...

New York:  Pfizer's vaccine that specifically targets the Omicron variant of Covid-19 will be ready in March, the pharmaceutical giant's CEO Albert Bourla has said. Bourla said Omicron is a more difficult target than the previous…
Read More...

Hong Kong: Contradicting the vaccine maker's pronouncement, a new study has found that a third dose of Sinovac's Covid-19 vaccine does not provide sufficient protection against the Omicron variant. According to Nikkei Asia, the…
Read More...